This percentage was higher than that of tumours with lower ZEB1 (9 KRAS-mutated tumours in a total of 31 tumours; 29%) (Fig. 1), but the association between KRAS mutations and ZEB1 expression changes was not statistically significant (Fisher's exact test, P=0.11). The gene discussed is ZEB1; the disease is neoplasm.